Stage III Cervical Cancer Completed Phase 2 Trials for Pegfilgrastim (DB00019)

Also known as: Cervical cancer stage III / Cervix uteri cancer stage III / Carcinoma uterine cerix stage III / Cervical carcinoma stage III / Carcinoma uterine cervix stage III / Cervix carcinoma stage III / Ca cervix stage III / Carcinoma cervix stage III

IndicationStatusPhase
DBCOND0028824 (Stage III Cervical Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01266447Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical CancerTreatment